Related Experiment Videos

[Comparison of O2-exposed premature infants with and without vitamin E substitution from the ophthalmologic

Kinderarztliche Praxis
|February 1, 1989
PubMed

Insights

Vitamin E supplementation may prevent severe retinopathy of prematurity (ROP) in premature infants receiving oxygen therapy. This study found lower rates of advanced ROP stages in infants treated with vitamin E.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Nutritional Science

Context:

  • Retinopathy of prematurity (ROP) is a significant cause of vision impairment in premature infants.
  • Oxygen therapy, while necessary, is a known risk factor for ROP development and progression.
  • Vitamin E is an antioxidant with potential protective effects against ROP.

Purpose:

  • To evaluate the efficacy of vitamin E in preventing the progression of retinopathy of prematurity (ROP) in premature infants.
  • To compare ROP outcomes in premature infants receiving oxygen therapy with and without vitamin E supplementation.

Summary:

  • This study compared 80 premature infants receiving oxygen therapy and vitamin E (1986) with 80 similar infants not receiving vitamin E (1984-1985).
  • Infants supplemented with vitamin E exhibited a reduced incidence of higher-stage ROP (stages II-V).
  • While promising, the study groups were not fully homogenous, limiting definitive statistical conclusions due to confounding factors.

Impact:

  • Suggests a potential therapeutic role for vitamin E in mitigating severe ROP outcomes.
  • Highlights the need for further controlled studies to confirm vitamin E's protective effects in ROP prevention.
  • Informs clinical practice regarding nutritional support for high-risk premature infants.

Related Concept Videos